KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Goodwill (2019 - 2024)

Ginkgo Bioworks Holdings filings provide 6 years of Goodwill readings, the most recent being $47.9 million for Q1 2024.

  • On a quarterly basis, Goodwill fell 18.42% to $47.9 million in Q1 2024 year-over-year; TTM through Mar 2024 was $47.9 million, a 18.42% decrease, with the full-year FY2023 number at $49.2 million, down 18.22% from a year prior.
  • Goodwill hit $47.9 million in Q1 2024 for Ginkgo Bioworks Holdings, down from $49.2 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $60.2 million in Q4 2022 to a low of $1.9 million in Q4 2020.
  • Median Goodwill over the past 5 years was $39.4 million (2022), compared with a mean of $37.8 million.
  • Biggest five-year swings in Goodwill: skyrocketed 1047.66% in 2021 and later dropped 18.42% in 2024.
  • Ginkgo Bioworks Holdings' Goodwill stood at $1.9 million in 2020, then skyrocketed by 1047.66% to $21.3 million in 2021, then soared by 182.52% to $60.2 million in 2022, then dropped by 18.22% to $49.2 million in 2023, then decreased by 2.7% to $47.9 million in 2024.
  • The last three reported values for Goodwill were $47.9 million (Q1 2024), $49.2 million (Q4 2023), and $58.1 million (Q3 2023) per Business Quant data.